Publications

Journal Article
Review
Epublish 94 citations
Electronic publication date
March 10, 2018

View on Pubmed.gov 29520309 | View on doi.org 10.3762/bjoc.14...

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review.

Search for publications in this journal Beilstein J Org Chem

Abstract

Ursodeoxycholic acid (UDCA) is a pharmaceutical ingredient widely used in clinics. As bile acid it solubilizes cholesterol gallstones and improves the liver function in case of cholestatic diseases. UDCA can be obtained from cholic acid (CA), which is the most abundant and least expensive bile acid available. The now available chemical routes for the obtainment of UDCA yield about 30% of final product. For these syntheses several protection and deprotection steps requiring toxic and dangerous reagents have to be performed, leading to the production of a series of waste products. In many cases the cholic acid itself first needs to be prepared from its taurinated and glycilated derivatives in the bile, thus adding to the complexity and multitude of steps involved of the synthetic process. For these reasons, several studies have been performed towards the development of microbial transformations or chemoenzymatic procedures for the synthesis of UDCA starting from CA or chenodeoxycholic acid (CDCA). This promising approach led several research groups to focus their attention on the development of biotransformations with non-pathogenic, easy-to-manage microorganisms, and their enzymes. In particular, the enzymatic reactions involved are selective hydrolysis, epimerization of the hydroxy functions (by oxidation and subsequent reduction) and the specific hydroxylation and dehydroxylation of suitable positions in the steroid rings. In this minireview, we critically analyze the state of the art of the production of UDCA by several chemical, chemoenzymatic and enzymatic routes reported, highlighting the bottlenecks of each production step. Particular attention is placed on the precursors availability as well as the substrate loading in the process. Potential new routes and recent developments are discussed, in particular on the employment of flow-reactors. The latter technology allows to develop processes with shorter reaction times and lower costs for the chemical and enzymatic reactions involved.

References

Hepatology. 1984 Sep-Oct;4(5 Suppl):66S-71S

Hepatology. 1995 Sep;22(3):759-66

Biochim Biophys Acta. 1976 Nov 19;450(2):142-53

Gastroenterology. 1989 Jan;96(1):222-9

Cited by 94 citations (total)

Journal Article

NAD -Dependent Enzymatic Route for the Epimerization of Hydroxysteroids.

Electronic publication date August 14, 2019

Search for publications in this journal ChemSusChem

Fabio Tonin [...] Isabel W C E Arends et al.

Epimerization of cholic and chenodeoxycholic acid (CA and CDCA, respectively) is a notable conversion for the production of ursodeoxycholic acid...

Journal Article

Cost-effective whole-cell biosynthesis of ursodeoxycholic acid using engineered with a multienzyme cascade.

Electronic publication date February 11, 2025

Search for publications in this journal Front Microbiol

Xue Zhang [...] Peng Song et al.

Ursodeoxycholic acid (UDCA) can be used as a drug to treat various liver and bile diseases. Currently, the biological synthesis...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties